ABSTRACT
The coronavirus disease 2019 pandemic has become a major global public health problem. Governments are taking the necessary steps to reduce the movement of people to contain the spread of the virus. However, these measures have caused considerable distress to patients with gastric cancer who are newly diagnosed or are undergoing treatment. In addition to the cancer, they must deal with longer waiting times for surgery and poor communication with doctors. Furthermore, gastric cancer patients generally have low immunity and a poor nutritional status, so they are a high-risk group for infection with the novel coronavirus. Therefore, it is necessary to formulate reasonable outpatient management strategies to reduce the adverse effects of the pandemic on their treatment. We summarize the management strategies for patients with gastric cancer during the pandemic.
ABSTRACT
To analyze the epidemiological characteristics and early clinical characteristics of patients with new coronavirus (2019-nCoV) infection in Kunming, and to provide evidence for clinical diagnosis and treatment. The epidemiological history, clinical symptoms, and laboratory test data of 41 of 2019-nCoV confirmed patients admitted to the isolation ward of The third People's Hospital of Kunming from January 23 to February 10, 2020 were retrospectively analyzed. The vast majority of 41 2019-nCoV confirmed patients were imported cases, with incubation periods ranging from 2 to 20 days;severe and critically ill patients were Severe and critically ill patients were older, had higher BMI, similar clinical symptoms, and lymphocytes than patients with mild and general type Lower counts, earlier changes in blood gas, higher erythrocyte sedimentation, lower CA and FE, and more significant decreases in CD4 and CD8 counts. The changes of lymphocyte count, blood gas, ESR, CA and FE and T lymphocyte subsets will appear earlier in the week before the disease is aggravated, which has a certain early warning effect on the severity of the disease.